Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 277

1.

Damage assessment in adult IgA vasculitis. Cross-sectional results of a multicentre cohort.

Gazel U, Colak S, Sari A, Cansu DÜ, Yazici A, Cefle A, Bes C, Karadag O, Omma A, Direskeneli H, Alibaz-Oner F.

Clin Exp Rheumatol. 2020 Feb 11. [Epub ahead of print]

PMID:
32083544
2.

Efficacy of TNFα inhibitors for refractory vascular Behçet's disease: A multicenter observational study of 27 patients and a review of the literature.

Aksoy A, Yazici A, Omma A, Cefle A, Onen F, Tasdemir U, Ergun T, Direskeneli H, Alibaz-Oner F.

Int J Rheum Dis. 2020 Feb;23(2):256-261. doi: 10.1111/1756-185X.13778. Epub 2020 Jan 24.

PMID:
31976619
3.

British Society for Rheumatology guideline on diagnosis and treatment of giant cell arteritis: executive summary.

Mackie SL, Dejaco C, Appenzeller S, Camellino D, Duftner C, Gonzalez-Chiappe S, Mahr A, Mukhtyar C, Reynolds G, de Souza AWS, Brouwer E, Bukhari M, Buttgereit F, Byrne D, Cid MC, Cimmino M, Direskeneli H, Gilbert K, Kermani TA, Khan A, Lanyon P, Luqmani R, Mallen C, Mason JC, Matteson EL, Merkel PA, Mollan S, Neill L, Sullivan EO, Sandovici M, Schmidt WA, Watts R, Whitlock M, Yacyshyn E, Ytterberg S, Dasgupta B.

Rheumatology (Oxford). 2020 Mar 1;59(3):487-494. doi: 10.1093/rheumatology/kez664. No abstract available.

PMID:
31970410
4.

British Society for Rheumatology guideline on diagnosis and treatment of giant cell arteritis.

Mackie SL, Dejaco C, Appenzeller S, Camellino D, Duftner C, Gonzalez-Chiappe S, Mahr A, Mukhtyar C, Reynolds G, de Souza AWS, Brouwer E, Bukhari M, Buttgereit F, Byrne D, Cid MC, Cimmino M, Direskeneli H, Gilbert K, Kermani TA, Khan A, Lanyon P, Luqmani R, Mallen C, Mason JC, Matteson EL, Merkel PA, Mollan S, Neill L, Sullivan EO, Sandovici M, Schmidt WA, Watts R, Whitlock M, Yacyshyn E, Ytterberg S, Dasgupta B.

Rheumatology (Oxford). 2020 Mar 1;59(3):e1-e23. doi: 10.1093/rheumatology/kez672. No abstract available.

PMID:
31970405
5.

Predictive factors for work-day loss in Behçet's syndrome: A multi-center study.

Mumcu G, Yay M, Aksoy A, Taş MN, Armağan B, Sarı A, Bozca BC, Tekgöz E, Karadağ DT, Badak SÖ, Tecer D, Bes C, Şahin A, Erken E, Cefle A, Çınar M, Yılmaz S, Karaçaylı Ü, Alpsoy E, Şenel S, Yaşar Bilge Ş, Kaşifoğlu T, Karadağ Ö, Aksu K, Keser G, Alibaz-Öner F, İnanç N, Ergun T, Direskeneli H.

Int J Rheum Dis. 2020 Feb;23(2):240-246. doi: 10.1111/1756-185X.13771. Epub 2019 Dec 19.

PMID:
31858715
6.

Oral ulcer activity assessment with the composite index according to different treatment modalities in Behçet's syndrome: a multicentre study.

Mumcu G, Karacayli Ü, Yay M, Aksoy A, Taş MN, Armağan B, Sari A, Bozca BC, Tekgöz E, Karadağ DT, Badak SÖ, Tecer D, Bes C, Şahin A, Erken E, Cefle A, Çinar M, Yilmaz S, Alpsoy E, Şenel S, Bilge ŞY, Kaşifoğlu T, Karadağ Ö, Aksu K, Keser G, Alibaz-Öner F, Inanç N, Ergun T, Direskeneli H.

Clin Exp Rheumatol. 2019 Nov-Dec;37 Suppl 121(6):98-104. Epub 2019 Dec 9.

7.

Evaluation of salivary gland ultrasonography in primary Sjögren's syndrome: does it reflect clinical activity and outcome of the disease?

Inanc N, Şahinkaya Y, Mumcu G, Türe Özdemir F, Paksoy A, Ertürk Z, Direskeneli H, Bruyn GA.

Clin Exp Rheumatol. 2019 May-Jun;37 Suppl 118(3):140-145. Epub 2019 Jul 5.

8.

Predictors and the optimal duration of sustained remission in rheumatoid arthritis.

Yilmaz-Oner S, Gazel U, Can M, Atagunduz P, Direskeneli H, Inanc N.

Clin Rheumatol. 2019 Nov;38(11):3033-3039. doi: 10.1007/s10067-019-04654-7. Epub 2019 Jul 3.

PMID:
31270696
9.

Advanced Glycation End Products, a Potential Link between Psoriasis and Cardiovascular Disease: A Case-control Study.

Ergun T, Yazici V, Yavuz D, Seckin-Gencosmanoglu D, Ozen G, Salman A, Direskeneli H, Inanc N.

Indian J Dermatol. 2019 May-Jun;64(3):201-206. doi: 10.4103/ijd.IJD_396_18.

10.

Assessment of venous wall thickness with Doppler ultrasonography may be a diagnostic tool for Behçet's disease.

Alibaz-Oner F, Direskeneli H.

Int J Rheum Dis. 2019 May;22(5):767-768. doi: 10.1111/1756-185X.13574. No abstract available.

PMID:
31062939
11.

Structural variation of centromeric endogenous retroviruses in human populations and their impact on cutaneous T-cell lymphoma, Sézary syndrome, and HIV infection.

Kaplan MH, Kaminski M, Estes JM, Gitlin SD, Zahn J, Elder JT, Tejasvi T, Gensterblum E, Sawalha AH, McGowan JP, Dosik MH, Direskeneli H, Direskeneli GS, Adebamowo SN, Adebamowo CA, Sajadi M, Contreras-Galindo R.

BMC Med Genomics. 2019 May 2;12(1):58. doi: 10.1186/s12920-019-0505-8.

12.

The distribution of MEFV mutations in Turkish FMF patients: multicenter study representing results of Anatolia

Yaşar Bilge Ş, Sarı İ, Solmaz D, Şenel S, Emmungil H, Kılıç L, Yılmaz Öner S, Yıldız F, Yılmaz S, Ersözlü Bozkırlı D, Aydın Tufan M, Yılmaz S, Yazısız V, Pehlivan Y, Bes C, Yıldırım Çetin G, Erten Ş, Gönüllü E, Şahin F, Akar S, Aksu K, Kalyoncu U, Direskeneli H, Erken E, Kısacık B, Sayarlıoğlu M, Çınar M, Kaşifoğlu T.

Turk J Med Sci. 2019 Apr 18;49(2):472-477. doi: 10.3906/sag-1809-100.

PMID:
30887796
13.

Update on Outcome Measure Development in Large-vessel Vasculitis: Report from OMERACT 2018.

Aydin SZ, Robson JC, Sreih AG, Hill C, Alibaz-Oner F, Mackie S, Beard S, Gul A, Hatemi G, Kermani TA, Mahr A, Meara A, Milman N, Shea B, Tómasson G, Tugwell P, Direskeneli H, Merkel PA.

J Rheumatol. 2019 Sep;46(9):1198-1201. doi: 10.3899/jrheum.181072. Epub 2019 Mar 15.

PMID:
30877212
14.

Venous vessel wall thickness in lower extremity is increased in male patients with Behcet's disease.

Alibaz-Oner F, Ergelen R, Mutis A, Erturk Z, Asadov R, Mumcu G, Ergun T, Direskeneli H.

Clin Rheumatol. 2019 May;38(5):1447-1451. doi: 10.1007/s10067-019-04470-z. Epub 2019 Feb 13.

PMID:
30758790
15.

Ocular Posterior Segment Involvement in Patients with Antiphospholipid Syndrome and Systemic Lupus Erythematosus.

Kucukkomurcu E, Unal AU, Esen F, Ozen G, Direskeneli H, Kazokoglu H.

Ocul Immunol Inflamm. 2020;28(1):86-91. doi: 10.1080/09273948.2018.1552759. Epub 2018 Dec 17.

PMID:
30556792
16.

Triggering agents and microbiome as environmental factors on Behçet's syndrome.

Mumcu G, Direskeneli H.

Intern Emerg Med. 2019 Aug;14(5):653-660. doi: 10.1007/s11739-018-2000-1. Epub 2018 Dec 6. Review.

PMID:
30523495
17.

Does illness perception associate with disease symptoms in Behçet's disease?

Mumcu G, Yağar F, Alibaz-Öner F, İnanç N, Direskeneli H, Ergun T.

Intern Emerg Med. 2019 Aug;14(5):691-697. doi: 10.1007/s11739-018-1983-y. Epub 2018 Nov 30.

PMID:
30506212
18.

The assessment of contributing factors to oral ulcer presence in Behçet's disease: Dietary and non-dietary factors.

İris M, Özçıkmak E, Aksoy A, Alibaz-Öner F, İnanç N, Ergun T, Direskeneli H, Mumcu G.

Eur J Rheumatol. 2018 Dec;5(4):240-243. doi: 10.5152/eurjrheum.2018.18094. Epub 2018 Oct 12.

19.

Exon 2: Is it the good police in familial mediterranean fever?

Bilge ŞY, Solmaz D, Şenel S, Emmungil H, Kılıç L, Öner SY, Yıldız F, Yılmaz S, Bozkırlı DE, Tufan MA, Yılmaz S, Yazısız V, Pehlivan Y, Beş C, Çetin GY, Erten Ş, Gönüllü E, Şahin F, Akar S, Aksu K, Kalyoncu U, Direskeneli H, Erken E, Kısacık B, Sayarlıoğlu M, Çınar M, Kaşifoğlu T, Sarı İ.

Eur J Rheumatol. 2019 Jan;6(1):34-37. doi: 10.5152/eurjrheum.2018.18115.

20.

Oral health is a mediator for disease severity in patients with Behçet's disease: A multiple mediation analysis study.

Yay M, Çelik Z, Aksoy A, Alibaz-Öner F, Inanç N, Ergun T, Direskeneli H, Mumcu G.

J Oral Rehabil. 2019 Apr;46(4):349-354. doi: 10.1111/joor.12750. Epub 2018 Dec 14.

PMID:
30466164
21.

Pulmonary hypertension in Takayasu's arteritis: Should be monitored closely.

Direskeneli H.

Int J Cardiol. 2019 Feb 1;276:238-239. doi: 10.1016/j.ijcard.2018.10.074. Epub 2018 Oct 28. No abstract available.

PMID:
30391066
22.

Factors Affecting Relapse and Remission in Behçet's Uveitis Treated with Interferon Alpha2a.

Celiker H, Kazokoglu H, Direskeneli H.

J Ocul Pharmacol Ther. 2019 Jan/Feb;35(1):58-65. doi: 10.1089/jop.2018.0083. Epub 2018 Oct 25.

PMID:
30359208
23.

Prevalence of inflammatory back pain and radiologic sacroiliitis is increased in patients with primary Sjögren's syndrome.

Eren R, Can M, Alibaz-Öner F, Yilmaz-Oner S, Yilmazer B, Cefle A, Direskeneli H, Atagündüz P.

Pan Afr Med J. 2018 Jun 5;30:98. doi: 10.11604/pamj.2018.30.98.15588. eCollection 2018.

24.

Conventional immunosuppressive therapy in severe Behcet's Uveitis: the switch rate to the biological agents.

Celiker H, Kazokoglu H, Direskeneli H.

BMC Ophthalmol. 2018 Oct 5;18(1):261. doi: 10.1186/s12886-018-0929-5.

25.

Analysis of the genetic component of systemic sclerosis in Iranian and Turkish populations through a genome-wide association study.

González-Serna D, López-Isac E, Yilmaz N, Gharibdoost F, Jamshidi A, Kavosi H, Poursani S, Farsad F, Direskeneli H, Saruhan-Direskeneli G, Vargas S, Sawalha AH, Brown MA, Yavuz S, Mahmoudi M, Martin J.

Rheumatology (Oxford). 2019 Feb 1;58(2):289-298. doi: 10.1093/rheumatology/key281.

PMID:
30247649
26.

Ocular findings and blood flow in patients with Takayasu arteritis: a cross-sectional study.

Esen F, Ergelen R, Alibaz-Öner F, Çelik G, Direskeneli H, Kazokoğlu H.

Br J Ophthalmol. 2019 Jul;103(7):928-932. doi: 10.1136/bjophthalmol-2018-312580. Epub 2018 Aug 27.

PMID:
30150277
27.

Takayasu arteritis: an update

Keser G, Aksu K, Direskeneli H.

Turk J Med Sci. 2018 Aug 16;48(4):681-697. doi: 10.3906/sag-1804-136. Review.

PMID:
30114347
28.

Certolizumab pegol in the treatment of Takayasu arteritis.

Novikov PI, Smitienko IO, Sokolova MV, Alibaz-Oner F, Kaymaz-Tahra S, Direskeneli H, Moiseev SV.

Rheumatology (Oxford). 2018 Dec 1;57(12):2101-2105. doi: 10.1093/rheumatology/key197.

PMID:
30010945
29.

Management of vascular Behçet's disease.

Alibaz-Oner F, Direskeneli H.

Int J Rheum Dis. 2019 Jan;22 Suppl 1:105-108. doi: 10.1111/1756-185X.13298. Epub 2018 Apr 17. Review.

PMID:
29665281
30.

Impaired cardiac and vascular motion in patients with Takayasu's arteritis: A velocity vector imaging-based study.

Yurdakul S, Alibaz-Öner F, Direskeneli H, Aytekin S.

Eur J Rheumatol. 2018 Mar;5(1):16-21. doi: 10.5152/eurjrheum.2017.16108. Epub 2017 Oct 25.

31.

Management of Behçet's disease.

Alibaz-Oner F, Sawalha AH, Direskeneli H.

Curr Opin Rheumatol. 2018 May;30(3):238-242. doi: 10.1097/BOR.0000000000000497. Review.

PMID:
29432223
32.

EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice.

Dejaco C, Ramiro S, Duftner C, Besson FL, Bley TA, Blockmans D, Brouwer E, Cimmino MA, Clark E, Dasgupta B, Diamantopoulos AP, Direskeneli H, Iagnocco A, Klink T, Neill L, Ponte C, Salvarani C, Slart RHJA, Whitlock M, Schmidt WA.

Ann Rheum Dis. 2018 May;77(5):636-643. doi: 10.1136/annrheumdis-2017-212649. Epub 2018 Jan 22.

33.

A genome-wide association study identifies nucleotide variants at SIGLEC5 and DEFA1A3 as risk loci for periodontitis.

Munz M, Willenborg C, Richter GM, Jockel-Schneider Y, Graetz C, Staufenbiel I, Wellmann J, Berger K, Krone B, Hoffmann P, van der Velde N, Uitterlinden AG, de Groot LCPGM, Sawalha AH, Direskeneli H, Saruhan-Direskeneli G, Guzeldemir-Akcakanat E, Keceli HG, Laudes M, Noack B, Teumer A, Holtfreter B, Kocher T, Eickholz P, Meyle J, Doerfer C, Bruckmann C, Lieb W, Franke A, Schreiber S, Nohutcu RM, Erdmann J, Loos BG, Jepsen S, Dommisch H, Schaefer AS.

Hum Mol Genet. 2018 Mar 1;27(5):941-942. doi: 10.1093/hmg/ddy015. No abstract available.

PMID:
29346566
34.

Comparison of early versus late onset familial Mediterranean fever.

Yasar Bilge NS, Sari I, Solmaz D, Senel S, Emmungil H, Kilic L, Yilmaz Oner S, Yildiz F, Yilmaz S, Ersozlu Bozkirli D, Aydin Tufan M, Yilmaz S, Yazisiz V, Pehlivan Y, Bes C, Yildirim Cetin G, Erten S, Gonullu E, Sahin F, Akar S, Aksu K, Kalyoncu U, Direskeneli H, Erken E, Sayarlioglu M, Cınar M, Kasifoglu T.

Int J Rheum Dis. 2018 Apr;21(4):880-884. doi: 10.1111/1756-185X.13259. Epub 2018 Jan 5.

PMID:
29314707
35.

Increased stiffness of median nerve in systemic sclerosis.

Yagci I, Kenis-Coskun O, Ozsoy T, Ozen G, Direskeneli H.

BMC Musculoskelet Disord. 2017 Nov 7;18(1):434. doi: 10.1186/s12891-017-1793-9.

36.

Nationwide Experience With Off-Label Use of Interleukin-1 Targeting Treatment in Familial Mediterranean Fever Patients.

Akar S, Cetin P, Kalyoncu U, Karadag O, Sari I, Cınar M, Yilmaz S, Onat AM, Kisacik B, Erden A, Balkarli A, Kucuksahin O, Oner SY, Senel S, Tufan A, Direskeneli H, Oksuz F, Pehlivan Y, Bayindir O, Keser G, Aksu K, Omma A, Kasifoglu T, Unal AU, Yildiz F, Balci MA, Yavuz S, Erten S, Ozgen M, Sayarlıoglu M, Dogru A, Yildirim G, Oner FA, Tezcan ME, Pamuk ON, Onen F.

Arthritis Care Res (Hoboken). 2018 Jul;70(7):1090-1094. doi: 10.1002/acr.23446. Epub 2018 Apr 24.

37.

Health-related outcomes of importance to patients with Takayasu's arteritis.

Sreih AG, Alibaz-Oner F, Easley E, Davis T, Mumcu G, Milman N, Robson J, Direskeneli H, Merkel PA, Cronholm P.

Clin Exp Rheumatol. 2018 Mar-Apr;36 Suppl 111(2):51-57. Epub 2017 Sep 18.

38.

Discrepancies between vascular and systemic inflammation in large vessel vasculitis: an important problem revisited.

Keser G, Aksu K, Direskeneli H.

Rheumatology (Oxford). 2018 May 1;57(5):784-790. doi: 10.1093/rheumatology/kex333. Review.

PMID:
28968895
39.

Assessment of the frequency of cardiovascular risk factors in patients with Takayasu's arteritis.

Alibaz-Oner F, Koster MJ, Unal AU, Yildirim HG, Çikikçi C, Schmidt J, Crowson CS, Makol A, Ytterberg SR, Matteson EL, Direskeneli H, Warrington KJ.

Rheumatology (Oxford). 2017 Nov 1;56(11):1939-1944. doi: 10.1093/rheumatology/kex300.

PMID:
28968808
40.

An update on the role of epigenetics in systemic vasculitis.

Coit P, Direskeneli H, Sawalha AH.

Curr Opin Rheumatol. 2018 Jan;30(1):4-15. doi: 10.1097/BOR.0000000000000451. Review.

41.

Could Sublingual Immunotherapy Affect Oral Health in Children with Asthma and/or Allergic Rhinitis Sensitized to House Dust Mite?

Kiykim A, Mumcu G, Ogulur I, Karakoc-Aydiner E, Direskeneli H, Baris S, Cagan H, Ozen A.

Int Arch Allergy Immunol. 2017;174(1):52-56. doi: 10.1159/000480082. Epub 2017 Sep 27.

PMID:
28950285
42.

OMERACT Endorsement of Patient-reported Outcome Instruments in Antineutrophil Cytoplasmic Antibody-associated Vasculitis.

Robson JC, Tomasson G, Milman N, Ashdown S, Boonen A, Casey GC, Cronholm PF, Cuthbertson D, Dawson J, Direskeneli H, Easley E, Kermani TA, Farrar JT, Gebhart D, Lanier G, Luqmani RA, Mahr A, McAlear CA, Peck J, Shea B, Shea JA, Sreih AG, Tugwell PS, Merkel PA.

J Rheumatol. 2017 Oct;44(10):1529-1535. doi: 10.3899/jrheum.161139. Epub 2017 Sep 1.

43.

Assessment of Disease Activity in Large-vessel Vasculitis: Results of an International Delphi Exercise.

Aydin SZ, Direskeneli H, Merkel PA; International Delphi on Disease Activity Assessment in Large-vessel Vasculitis.

J Rheumatol. 2017 Dec;44(12):1928-1932. doi: 10.3899/jrheum.161269. Epub 2017 Sep 1.

44.

Development of a Core Set of Outcome Measures for Large-vessel Vasculitis: Report from OMERACT 2016.

Sreih AG, Alibaz-Oner F, Kermani TA, Aydin SZ, Cronholm PF, Davis T, Easley E, Gul A, Mahr A, McAlear CA, Milman N, Robson JC, Tomasson G, Direskeneli H, Merkel PA.

J Rheumatol. 2017 Dec;44(12):1933-1937. doi: 10.3899/jrheum.161467. Epub 2017 Sep 1.

45.

Takayasu's arteritis: A new era is approaching.

Direskeneli H.

Presse Med. 2017 Jul - Aug;46(7-8 Pt 2):e177. doi: 10.1016/j.lpm.2017.08.006. No abstract available.

PMID:
28843640
46.

Outcomes of Patients with Behçet's Syndrome after Pulmonary Endarterectomy.

Yıldızeli ŞO, Yanartaş M, Taş S, Direskeneli H, Mutlu B, Ceyhan B, Yıldızeli B.

Thorac Cardiovasc Surg. 2018 Mar;66(2):187-192. doi: 10.1055/s-0037-1604411. Epub 2017 Aug 15.

PMID:
28810271
47.

Patient-reported outcomes in Takayasu's arteritis.

Alibaz-Oner F, Sreih AG, Merkel PA, Direskeneli H.

Presse Med. 2017 Jul - Aug;46(7-8 Pt 2):e225-e227. doi: 10.1016/j.lpm.2017.03.023. Epub 2017 Jul 26.

PMID:
28756078
48.

Long-Term Efficacy of Pegylated Interferon Alpha-2b in Behçet's Uveitis: A Small Case Series.

Celiker H, Kazokoglu H, Direskeneli H.

Ocul Immunol Inflamm. 2019;27(1):15-22. doi: 10.1080/09273948.2017.1332768. Epub 2017 Jul 12.

PMID:
28700247
49.

Oral ulcer activity in Behcet's disease: Poor medication adherence is an underestimated risk factor.

Mumcu G, Alibaz-Öner F, Öner SY, Özen G, Atagündüz P, İnanç N, Köksal L, Ergun T, Direskeneli H.

Eur J Rheumatol. 2017 Jun;4(2):109-112. doi: 10.5152/eurjrheum.2017.160094. Epub 2017 Jun 1.

50.

A genome-wide association study identifies nucleotide variants at SIGLEC5 and DEFA1A3 as risk loci for periodontitis.

Munz M, Willenborg C, Richter GM, Jockel-Schneider Y, Graetz C, Staufenbiel I, Wellmann J, Berger K, Krone B, Hoffmann P, van der Velde N, Uitterlinden AG, de Groot LCPGM, Sawalha AH, Direskeneli H, Saruhan-Direskeneli G, Guzeldemir-Akcakanat E, Keceli HG, Laudes M, Noack B, Teumer A, Holtfreter B, Kocher T, Eickholz P, Meyle J, Doerfer C, Bruckmann C, Lieb W, Franke A, Schreiber S, Nohutcu RM, Erdmann J, Loos BG, Jepsen S, Dommisch H, Schaefer AS.

Hum Mol Genet. 2017 Jul 1;26(13):2577-2588. doi: 10.1093/hmg/ddx151. Erratum in: Hum Mol Genet. 2018 Mar 1;27(5):941-942.

PMID:
28449029

Supplemental Content

Loading ...
Support Center